Autologous vs. Allogeneic Stem Cell Transplants: Revolutionizing Neurology
Stem cell therapy represents a frontier in medical science, offering new hope and avenues for treatment in various fields, including neurology. This dynamic area of medicine harnesses the power of stem cells, the body’s raw materials from which all other cells with specialized functions are generated. In neurology, stem cell transplants are gaining attention for […]
Neural Stem Cell Transplantation in Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a complex medical condition that has been a focal point of neuroscientific research for decades. As a leading cause of death and disability worldwide, TBI presents unique challenges, both in its treatment and in the management of its long-term effects. However, recent advancements in the field of regenerative medicine, particularly […]
Revolution in Oncology: How Stem Cell Transplants are Changing the Game in Cancer Treatment
Welcome, dear reader! It’s a pleasure to have you here as we embark on an enlightening journey into the world of stem cell transplants in oncology. This article is designed for those who are keen to learn more about cancer treatment options or are simply intrigued by the latest advancements in medical science. Consider this […]
Father’s Gift of Life: Young Cancer Warrior Levi Triumphs with Dad’s Stem Cell Help
7-year-old Levi Galvez celebrated being cancer-free at Riley Hospital in Indianapolis on March 27, after a five-year battle with leukemia that began when he was two years old. His father, Geovani Galvez, provided a life-saving stem cell transplant a year ago. The family celebrated the milestone with cheers, laughter, and a small ceremony. Geovani, who […]
Another Patient Cleared of HIV with Stem Cell Transplant
A 53-year-old man in Germany, referred to as the ‘Düsseldorf patient’, has become the fifth person to be declared cleared of HIV after a bone marrow transplant that replaced his cells with HIV-resistant stem cells from a donor. The procedure was first used on Timothy Ray Brown, the ‘Berlin patient,’ in 2007, and later on […]
ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers
MONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today the completion of patient enrollment in its initial Phase 2 studies for high-risk leukemias and myelodysplastic syndromes (MDS). ECT-001 Cell Therapy, ExCellThera’s most advanced investigational drug, combines the proprietary molecule UM171 and an […]
Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022
TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ — We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide. This year’s official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking […]
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, today announced that a patient has completed the course of investigational nomacopan treatment in the open-label, multi-center Phase III Part A clinical trial in pediatric hematopoietic stem cell transplant-related […]
Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022. Ronald Martell, Chief Executive Officer, Jeet Mahal, Chief Operating & […]
Autologous Stem Cell Transplants for Blood Cancer Patients
This animated video explains the purpose and procedure of Autologous Stem Cell Transplants for blood cancer patients. Video Transcript: Autologous stem cell transplants are a type of treatment for certain blood cancers that require very high doses of chemotherapy or radiation to treat their disease. Chemotherapy or chemo may kill cancer cells, but it also […]